American Express (AXP) Insider Notice: 23,505 Shares via Option Exercise

Rhea-AI Filing Summary

American Express Company (AXP) Form 144 notice reports a proposed sale of common stock totaling 23,505 shares with an aggregate market value of $7,671,425.57, to be executed through Morgan Stanley Smith Barney LLC on the NYSE on 09/02/2025. The filing states these shares were acquired and paid for on 09/02/2025 by exercise of options under a registered plan and payment was made in cash. The filer reports no securities sold in the past three months. Several identifying fields (filer CIK/CCC and specific person name) are not provided in the text supplied.

Positive

• Transaction details are disclosed: class, broker, share count, aggregate market value, sale date, and exchange are provided
• Acquisition method specified: shares were acquired by exercise of options under a registered plan and paid in cash
• No recent sales: filer reports no securities sold in the past three months

Negative

• Missing filer identifiers: filer CIK/CCC and the specific person for whose account the sale is to be made are not included in the provided text
• Limited disclosure for attribution: inability to identify the insider reduces transparency for investors assessing insider activity

Insights

Securities Analyst

TL;DR: Routine insider sale notice: 23,505 shares ($7.67M) via option exercise, executed through Morgan Stanley on 09/02/2025.

This Form 144 documents a proposed sale tied to an immediate exercise-and-sell transaction under a registered plan. The size of the sale (23,505 shares) represents a small fraction of the reported outstanding shares (695,882,227), suggesting limited dilution or market impact solely from this transaction. The filing notes cash payment and no sales in the prior three months, which supports that this is an isolated disposition. Several standard identifying fields are omitted in the provided text, limiting the ability to link the trade to a specific insider or quantify insider ownership changes.

Corporate Governance Expert

TL;DR: Procedural compliance appears met for a Rule 144 notice; missing filer identifiers reduce disclosure completeness.

The form indicates compliance with Rule 144 timing by providing transaction details, broker, and nature of acquisition (option exercise). The representation regarding absence of undisclosed material information is included. However, the supplied content does not include the filers identifying CIK/CCC or the named person for whose account the securities will be sold, which limits transparency about which insider or affiliated party is executing the sale. From a governance perspective, full identification is important for investor assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	23505	7671425.57	695882227	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of options under a registered plan	Issuer			23505	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AXP Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 23,505 common shares with an aggregate market value of $7,671,425.57 to be sold on 09/02/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

How were the AXP shares acquired that are being sold?

The shares were acquired on 09/02/2025 by exercise of options under a registered plan and payment was made in cash on the same date.

Does the filing show recent prior sales by the same person?

The filing states "Nothing to Report" for securities sold during the past three months, indicating no reported disposals in that period.

Which broker is handling the proposed sale for AXP?

The broker named in the filing is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.

What fraction of outstanding shares does this sale represent?

The filing lists 23,505 shares against 695,882,227 shares outstanding; the document provides these numbers but does not compute the percentage.